146 related articles for article (PubMed ID: 38468436)
1. Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations.
Zhang ZG; Zhu HM; Hua HK
Skin Res Technol; 2024 Mar; 30(3):e13618. PubMed ID: 38468436
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the role of wound healing genes in skin cutaneous melanoma: Insights into expression, methylation, mutations, and therapeutic implications.
Zhang Y; Gao C; Luo J; Khan A; Salem-Bekhit MM; Salem MM; Qi Z; Jiang B
Int Wound J; 2024 Apr; 21(4):e14807. PubMed ID: 38591163
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of downregulated NISCH expression in skin cutaneous melanoma: Modulation of tumor cell invasion, migration, and EMT via PAK1 inhibition.
Hua HK; Zhu HM; Zhang ZG
Tissue Cell; 2024 May; 88():102399. PubMed ID: 38723330
[TBL] [Abstract][Full Text] [Related]
4. The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients.
Wang X; Xiong H; Liang D; Chen Z; Li X; Zhang K
BMC Cancer; 2020 May; 20(1):378. PubMed ID: 32370744
[TBL] [Abstract][Full Text] [Related]
5. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM).
Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S
J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of the paired box gene 3 inhibits the progression of skin cutaneous melanoma by inhibiting c-MET tyrosine kinase : PAX3 downregulation inhibits melanoma progression.
Zhang K; Yu C; Tian R; Zhang W; Tang S; Wang G
Mol Biol Rep; 2022 Oct; 49(10):9137-9145. PubMed ID: 36057879
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-related protein: potential therapeutic target for melanoma invasion and metastasis.
Huang DC; Yang XF; Ochietti B; Fadhil I; Camirand A; Kremer R
Endocrinology; 2014 Oct; 155(10):3739-49. PubMed ID: 25051432
[TBL] [Abstract][Full Text] [Related]
8. Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells.
Si L; Yan X; Hao W; Ma X; Ren H; Ren B; Li D; Dong Z; Zheng Q
Oncol Rep; 2018 May; 39(5):2160-2170. PubMed ID: 29565458
[TBL] [Abstract][Full Text] [Related]
9. Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways.
Li CY; Wang Q; Wang XM; Li GX; Shen S; Wei XL
Eur J Pharmacol; 2019 Dec; 864():172719. PubMed ID: 31586634
[TBL] [Abstract][Full Text] [Related]
10. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
Yao X; Jiang W; Yu D; Yan Z
Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726
[TBL] [Abstract][Full Text] [Related]
11. Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/β-Catenin Signaling.
Zhang L; Chen J; Chen Y; Zou D; Pu Y; Wei M; Huang Y; Li Y; Huang Q; Chen J
Anticancer Agents Med Chem; 2023; 23(1):94-104. PubMed ID: 35598249
[TBL] [Abstract][Full Text] [Related]
12. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
13. DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma.
Xue W; Zhu H; Liu H; He H
Front Oncol; 2022; 12():799185. PubMed ID: 35651810
[TBL] [Abstract][Full Text] [Related]
14. Chrysin inhibit human melanoma A375.S2 cell migration and invasion via affecting MAPK signaling and NF-κB signaling pathway in vitro.
Chen HY; Jiang YW; Kuo CL; Way TD; Chou YC; Chang YS; Chung JG
Environ Toxicol; 2019 Apr; 34(4):434-442. PubMed ID: 30578657
[TBL] [Abstract][Full Text] [Related]
15. CADM1/TSLC1 inhibits melanoma cell line A375 invasion through the suppression of matrix metalloproteinases.
You Y; Zhang J; Li Y; Li Y; Shi G; Ma L; Wei H
Mol Med Rep; 2014 Nov; 10(5):2621-6. PubMed ID: 25215547
[TBL] [Abstract][Full Text] [Related]
16. α-Enolase inhibits apoptosis and promotes cell invasion and proliferation of skin cutaneous melanoma.
Zhang K; Tian R; Zhang W; Li Y; Zeng N; Liang Y; Tang S
Mol Biol Rep; 2022 Sep; 49(9):8241-8250. PubMed ID: 35925486
[TBL] [Abstract][Full Text] [Related]
17. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
Badiola I; Villacé P; Basaldua I; Olaso E
Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
[TBL] [Abstract][Full Text] [Related]
19. Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments.
Bai R; Yin P; Xing Z; Wu S; Zhang W; Ma X; Gan X; Liang Y; Zang Q; Lei H; Wei Y; Zhang C; Dai B; Zheng Y
Apoptosis; 2024 Apr; 29(3-4):372-392. PubMed ID: 37945816
[TBL] [Abstract][Full Text] [Related]
20. GBP2 Is a Favorable Prognostic Marker of Skin Cutaneous Melanoma and Affects Its Progression via the Wnt/β-catenin Pathway.
Ji G; Luo B; Chen L; Shen G; Tian T
Ann Clin Lab Sci; 2021 Nov; 51(6):772-782. PubMed ID: 34921030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
